Highlights
NASDAQ: CATB       Catabasis Pharma
Last Price Today's Change   Day's Range   Trading Volume
6.04   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):242,450
4 Weeks Range:5.94 - 6.87
4 Weeks Price Volatility (%):
87.92%
52 Weeks Range:2.74 - 8.59
52 Weeks Price Volatility (%):
70.31%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis. Geographically it operates thorough United States and derives revenue from sale of products.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

9227 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.680.00 
 HIPS 11.7670.00 
 HONE 8.900.00 
 ENZL 60.4260.00 
 KOD 77.510.00 
 UPRO 59.220.00 
 COLD 36.330.00 
 ALYA 2.850.00 
 CIGI 67.100.00 
 AXNX 47.710.00